Our media section contains our recent and archived corporate videos, interviews and presentations
| 24 Apr 24 | Jeremy Skillington, PhD, CEO, Poolbeg Pharma, ‘It’s like a checkbox of everything you wanted’, episode 64 | Listen |
| 13 Mar 24 | Q&A with Poolbeg CEO Jeremy Skillington & Chief Business Office David Allmond | Watch |
| 4 Mar 24 | Poolbeg Pharma POLB – CEO Jeremy Skillington talks to Alan Green | Watch |
| 15 Feb 24 | hVIVO chair Cathal Friel explains share sale; new executive role at Poolbeg Pharma | Watch |
| 12 Feb 24 | Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies | Watch |
| 8 Feb 24 | Poolbeg Pharma’s Allmond hopes to replicate Amryt success | Watch |
| 7 Feb 24 | Poolbeg Pharma’s new VP of Clinical Operations Laura Maher aims to help progress development assets | Watch |
| 23 Jan 24 | Poolbeg Pharma CLO reveals what he’s “looking to get his teeth into” in 2024 | Watch |
| 18 Jan 24 | Poolbeg Pharma Plc – Company Update January 2024 | Watch |
| 18 Jan 24 | Poolbeg Pharma announces more “very positive” efficacy data for POLB 001 | Watch |
| 17 Jan 24 | Q&A: Poolbeg Pharma on target for $1bn cancer opportunity | Open |
| 11 Nov 23 | POOLBEG PHARMA PLC – Company Update: November 2023 | Watch |
| 7 Nov 23 | POLB 001 Oncology Programme Update: November 2023 | Watch |
| 17 Oct 23 | Poolbeg Pharma unveils new collaboration agreement | Watch |
| 17 Oct 23 | Poolbeg Pharma Partners with a Nasdaq-Listed Biopharma Company on its Oral Delivery Platform | Watch |
| 13 Oct 23 | AI & Lab Automation: What are the key benefits and latest innovations to be aware of? | Watch |
| 25 Sep 23 | Master Investor Sector Focus: Healthcare | Watch |
| 20 Sep 23 | AI Unleashed: Experts from Poolbeg Pharma & CytoReason | Watch |
| 13 Sep 23 | Jeremy Skillington of Poolbeg Pharma: 2023 saw significant progress in advancing our pipeline | Listen |
| 13 Sep 23 | Poolbeg Pharma “moving forward rapidly” with POLB001 | Watch |
| 4 Sep 23 | Poolbeg Pharma A.I. Unlocking the power of unique human challenge trial data | Watch |
| 30 Aug 23 | Scientific Advisor at Poolbeg Pharma: Paula Maquire | Watch |
| 8 Aug 23 | CEO Jeremy Skillington talks to Alan Green | Watch |
| 8 Aug 23 | Poolbeg Pharma: Using AI to prepare for the next pandemic | Listen |
| 21 Jul 23 | VP of Regulatory Affairs of Poolbeg Pharma: Bruno Speder | Watch |
| 10 Jul 23 | Poolbeg Pharma at the forefront of AI drug discovery as it approaches IPO anniversary | Watch |
| 29 Jun 23 | Poolbeg Pharma and CytoReason identify “very exciting influenza targets” | Watch |
| 29 Jun 23 | Q&A: Poolbeg Pharma CEO Jeremy Skillington on its groundbreaking AI collaboration | Listen |
| 22 Jun 23 | Poolbeg Pharma sees “significant commercial opportunity” in oral vaccines | Watch |
| 22 Jun 23 | Jeremy Skillington of Poolbeg: This is a key step in the creation of a Phase I clinical trial ready oral vaccine candidate | Listen |
| 26 May 23 | Poolbeg Pharma’s new NED looking at “new opportunities” for the business | Watch |
| 17 May 23 | BioCentury Podcast – Fundraising struggles, an LSE surprise and Ireland’s burgeoning biotech ecosystem | Listen |
| 5 Apr 23 | Professor Siobhan McClean on Vaccine Candidates | Watch |
| 31 Mar 23 | POOLBEG PHARMA PLC – Full Year Results | Watch |
| 30 Mar 23 | Poolbeg Pharma “in a very healthy cash position” after first full year of operations | Watch |
| 30 Mar 23 | Poolbeg’s Jeremy Skillington on a groundbreaking year | Listen |
| 3 Mar 23 | POOLBEG PHARMA PLC – Company Presentation (Investor Meet) | Watch |
| 2 Mar 23 | Poolbeg Pharma “couldn’t be happier” with POLB 001 human challenge trial data | Watch |
| 2 Mar 23 | Poolbeg’s Jeremy Skillington: “the results are as good as we hoped for” | Listen |
| 1 Mar 23 | Poolbeg CEO Jeremy Skillington gave a POLB 001 update & explained how they use AI to speed discovery | Watch |
| 27 Feb 23 | Poolbeg Pharma & OneThree Biotech: Collaboration and Themes in AI | Watch |
| 24 Feb 23 | Poolbeg Pharma “really open” to different types of deal for POLB 001 | Watch |
| 20 Feb 23 | Poolbeg Pharma Investment Case | Watch |
| 11 Feb 23 | Elaine Sullivan on International Day of Women & Girls in Science | Watch |
| 20 Jan 23 | POLB 001, a potential companion therapy for CAR T Cell Therapy | Watch |
| 16 Jan 23 | POOLBEG PHARMA PLC – Investor Presentation | Watch |
| 16 Jan 23 | Poolbeg Pharma announces expansion of POLB 001 into oncology | Watch |
| 16 Jan 23 | Vox Markets Podcast: Jeremy Skillington, CEO Poolbeg Pharma | Listen |
| 9 Jan 23 | Poolbeg Pharma upbeat on preliminary influenza drug results | Watch |
| 9 Jan 23 | Jeremy Skillington of Poolbeg Pharma: Early data read out for POLB 001 indicates a successful LPS human challenge trial | Listen |
| 3 Jan 23 | Year in Review 2022 | Watch |
| 21 Dec 22 | Poolbeg Pharma identifies new RSV drug candidates | Watch |
| 21 Dec 22 | Jeremy Skillington of Poolbeg Pharma: First time RSV drug candidates have been identified using AI | Listen |
| 21 Dec 22 | Poolbeg Pharma year in review: fighting disease with AI | Watch |
| 15 Dec 22 | POOLBEG PHARMA PLC – Investor Presentation | Watch |
| 14 Dec 22 | Jeremy Skillington of Poolbeg Pharma: licence acquired to use innovative oral delivery technology to address large, fast-growing opportunity | Listen |
| 14 Dec 22 | Poolbeg Pharma makes “interesting addition to existing collaboration” | Watch |
| 13 Dec 22 | Poolbeg Pharma has its sights on exchange listing | Watch |
| 13 Dec 22 | POLB 001 LPS human challenge clinical trial successfully completed | Watch |
| 12 Dec 22 | Jeremy Skillington of Poolbeg Pharma: POLB 001 LPS human challenge clinical trial successfully completed | Listen |
| 12 Dec 22 | Poolbeg Pharma receives initial results from human challenge clinical study | Watch |
| 8 Dec 22 | LSX Poolbeg Showcase Presentation | Watch |
| 30 Nov 22 | Capital Markets Day | Open |
| 21 Nov 22 | Introduction to David English, VP of Business Development | Watch |
| 18 Nov 22 | Poolbeg Pharma & OneThree Biotech on AI programme for RSV drug targets | Watch |
| 15 Nov 22 | Jeremy Skillington of Poolbeg Pharma discusses their consortium award of €2.3m in non-dilutive grant funding | Listen |
| 15 Nov 22 | Poolbeg Pharma wins first non-dilutive grant funding | Watch |
| 8 Nov 22 | Jeremy Skillington of Poolbeg: First time AI has been used to identify multiple disease targets in RSV | Listen |
| 8 Nov 22 | Poolbeg Pharma makes virus “breakthrough” using AI drug discovery technology | Watch |
| 8 Nov 22 | Poolbeg Pharma presents at the London South East Investor Webinar | Watch |
| 18 Oct 22 | Poolbeg Pharma & UCD on completion in-licence of Melioidosis vaccine candidate | Watch |
| 6 Oct 22 | Poolbeg Pharma presents at the Proactive One2One Investor Forum – October 6th 2022 | Watch |
| 5 Oct 22 | StockBox Premiere with Oxford Cannabinoid, Poolbeg Pharma & Destiny Pharma | Watch |
| 21 Sep 22 | Poolbeg Pharma PLC pushes further with vaccine | Watch |
| 21 Sep 22 | Jeremy Skillington of Poolbeg: exclusive agreement with University College Dublin for a late preclinical stage vaccine candidate for Melioidosis | Listen |
| 19 Sep 22 | Cash flush Poolbeg Pharma says investors should watch out for a number of near-term value catalysts | Watch |
| 7 Sep 22 | 2022 Interim Results: Financial & Corporate Highlight Interview with BRR Media | Watch |
| 6 Sep 22 | Poolbeg interim results highlight strong cash position and significant advancement of porfolio. | Open |
| 6 Sep 22 | Poolbeg Pharma advancing portfolio of products and platforms which is ‘driving value’ | Watch |
| 6 Sep 22 | POOLBEG PHARMA PLC – Interim Results | Watch |
| 28 Jul 22 | A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington | Watch |
| 20 Jul 22 | POLB 001 achieves regulatory approval to commence human challenge clinical trial | Listen |
| 20 Jul 22 | Poolbeg Pharma achieves major milestone with POLB 001 human challenge clinical trial ready to start | Watch |
| 20 Jul 22 | POLB 001 Human Challenge Trial Ready to Commence | Watch |
| 14 Jul 22 | Proactive One2One Investor Presentation | Watch |
| 27 Jun 22 | Poolbeg Pharma is advancing an AI venture to help combat RSV | Watch |
| 27 Jun 22 | AI partner has completed build & optimisation of RSV human challenge data | Listen |
| 23 Jun 22 | OTC Virtual Investor Conference, Life Science Presentation | Watch |
| 9 Jun 22 | Poolbeg Pharma (POLB) – Sharesoc Webinar | Watch |
| 6 Jun 22 | Poolbeg Pharma Presentation at UK Investor Show | Watch |
| 30 May 22 | Poolbeg Pharma announce two US patents | Watch |
| 27 May 22 | Jeremy Skillington of Poolbeg Pharma talks about U.S. patents granted for POLB 001 & POLB 002 | Listen |
| 15 May 22 | LSX World Congress Showcase Poolbeg Pharma | Watch |
| 12 May 22 | Alan Bell discusses POLB 001 Update & GMP Manufacturing Contract | Watch |
| 28 Apr 22 | Poolbeg Pharma delighted with outcome of in-Specie offer | Watch |
| 27 Apr 22 | Poolbeg Pharma PLC presenting at the One2One Forum 26th April 2022 | Watch |
| 27 Apr 22 | Cathal Friel on Results of the proposal to purchase shares from Distribution in Specie shareholders | Watch |
| 27 Apr 22 | Cathal Friel of Poolbeg Pharma discusses results of the proposal to purchase shares from distribution in specie shareholders | Listen |
| 21 Apr 22 | Warwick University Professors Nigel Dimmock & Andrew Easton on POLB 002 | Watch |
| 15 Apr 22 | Poolbeg Pharma delighted with patent for flu treatment candidate | Watch |
| 11 Apr 22 | Cathal Friel of Poolbeg Pharma: Specie share purchase should increase liquidity & maximise shareholder value | Listen |
| 11 Apr 22 | Poolbeg Pharma PLC proposed share transfer is validation that shares are “cheap at this price” | Watch |
| 1 Apr 22 | Poolbeg Pharma POLB 001 Clinical Development – Clinical Trial Agreement Signed | Watch |
| 31 Mar 22 | CEO Jeremy Skillington on Poolbeg Pharma’s OTCQB Listing | Watch |
| 31 Mar 22 | Jeremy Skillington of Poolbeg Pharma discusses the clinical trial agreement for POLB 001 human challenge study | Listen |
| 25 Mar 22 | Jeremy Skillington & Luke O’Neill on Poolbeg’s AI Programme | Watch |
| 24 Mar 22 | Poolbeg Pharma plan to ‘unlock’ the influenza disease with CytoReason after signing AI deal | Watch |
| 24 Mar 22 | Jeremy Skillington of Poolbeg Pharma discusses their deal with CytoReason, a leading AI company | Listen |
| 4 Mar 22 | POOLBEG PHARMA PLC – Investor Presentation | Watch |
| 3 Mar 22 | Poolbeg Pharma Results to 31 December 2021 – Chairman & CEO | Watch |
| 3 Mar 22 | Cathal Friel & Jeremy Skillington of Poolbeg Pharma discuss the significant progress since IPO & growing pipeline | Listen |
| 3 Mar 22 | Poolbeg Pharma making ‘excellent progress post IPO as momentum builds’ | Watch |
| 1 Mar 22 | Brad Pryde on OneThree AI deal with Poolbeg Pharma | Watch |
| 28 Feb 22 | Liam Tremble – Project Manager, R&D Operations on OneThree AI Deal | Watch |
| 24 Feb 22 | Poolbeg Pharma’s Jeremy Skillington presents new deal with AI in developing new RSV drugs | Watch |
| 24 Feb 22 | Jeremy Skillington of Poolbeg Pharma discusses the Artificial Intelligence deal with OneThree Biotech | Listen |
| 9 Feb 22 | Poolbeg Pharma CEO Jeremy Skillington tells London South East 2022 is all about execution | Watch |
| 31 Jan 22 | Oral Vaccine Delivery Platform – BRR Media Interview | Watch |
| 31 Jan 22 | Poolbeg Pharma sign licence agreement with AnaBio Technologies to develop oral vaccine platform | Watch |
| 20 Jan 22 | Presenting at the proactive One2One Virtual Forum | Watch |
| 17 Jan 22 | Poolbeg Pharma in-licencing exciting programmes ready for big pharma | Watch |
| 17 Jan 22 | Poolbeg Pharma present deal with the University of Warwick for respiratory virus infections | Watch |
| 17 Jan 22 | Growing a Capital Light Company CEO Jeremy Skillington talks to Alan Green | Watch |
| 10 Jan 22 | Poolbeg Pharma to develop oral vaccine delivery platform | Watch |
| 5 Jan 22 | Poolbeg Pharma Progress in 2021 – BRR Media | Watch |
| 17 Dec 21 | ShareTalk interview on Oral Vaccine Development collaboration with AnaBio | Watch |
| 9 Dec 21 | Proactive One2One Virtual Forum | Watch |
| 6 Dec 21 | Poolbeg Pharma plc – Agreement signed for MelioVac with University College Dublin | Open |
| 1 Dec 21 | Introduction to Dr Elaine Sullivan – Scientific Advisor Board | Watch |
| 22 Nov 21 | Poolbeg Pharma presents at MelloMonday | Watch |
| 19 Nov 21 | POLB 001 Update | Watch |
| 18 Nov 21 | Poolbeg Pharma makes progress with POLB 001, its lead asset for the treatment of severe influenza | Watch |
| 18 Nov 21 | Cathal Friel & Jeremy Skillington of Poolbeg Pharma discuss progress on their lead asset POLB 001 | Listen |
| 9 Nov 21 | Poolbeg Pharma #POLB – Exec Chairman Cathal Friel & CEO Jeremy Skillington talk to Alan Green | Watch |
| 9 Nov 21 | Poolbeg Pharma’s access to vast array of human challenge data & samples | Watch |
| 21 Oct 21 | Jeremy Skillington Poolbeg Pharma Overview | Watch |
| 20 Oct 21 | Open Orphan pharma spin-out Poolbeg Pharma present at London South East’s October live event | Watch |
| 14 Oct 21 | Poolbeg Pharma makes moves to protect its virus diagnostic platform by filing for a patent | Watch |
| 14 Oct 21 | Jeremy Skillington of Poolbeg Pharma provides an update on new patent filings for its PredictViral™ platform | Listen |
| 12 Oct 21 | Poolbeg Pharma (POLB) – Jeremy Skillington, CEO & Cathal Friel, Chairman | Watch |
| 11 Oct 21 | Poolbeg Pharma and Future Pandemic Prevention & Preparedness | Watch |
| 11 Oct 21 | Poolbeg Pharma partner with Eurofins Genomics for AI data analysis | Watch |
| 7 Oct 21 | Jeremy Skillington of Poolbeg Pharma explains their RNA sequencing partnership with a leading global biopharma services company | Listen |
| 7 Oct 21 | Poolbeg Pharma reveal ‘exciting step’ with AI data analysis programme with Eurofins Genomics | Watch |
| 6 Oct 21 | New Therapeutics and Vaccines | Watch |
| 30 Sep 21 | Professor Luke O’Neill thoughts on Poolbeg Pharma’s POLB 001 | Watch |
| 29 Sep 21 | Poolbeg One2One Questions Answered Part 1 | Watch |
| 29 Sep 21 | Poolbeg One2One Questions Answered Part 2 | Watch |
| 29 Sep 21 | One2One Questions Answered Part 1 | Watch |
| 29 Sep 21 | One2One Questions Answered Part 2 | Watch |
| 27 Sep 21 | Luke O’Neill Poolbeg Pharma Interview with BRR Media | Watch |
| 23 Sep 21 | Professor Luke O’Neill background and reasons for joining Poolbeg Pharma | Watch |
| 16 Sep 21 | Poolbeg Pharma Presenting at the Proactive One2One Virtual Forum | Watch |
| 7 Sep 21 | Poolbeg Pharma – inspiration for the name | Watch |
| 2 Sep 21 | Poolbeg Pharma Leadership Team | Watch |
| 25 Aug 21 | Poolbeg Pharma Investor Information | Watch |
| 16 Aug 21 | Poolbeg Pharma – Broad Asset Portfolio | Watch |
| 11 Aug 21 | Poolbeg Pharma is building a leading infectious disease company with a wide asset portfolio | Watch |
| 22 Jul 21 | Poolbeg Pharma plc joins London Stock Exchange | Watch |
| 20 Jul 21 | Poolbeg CEO Jeremy Skillington & Chairman Cathal Friel – BRR Media | Watch |
| 20 Jul 21 | Jeremy Skillington, CEO – Poolbeg Pharma | Watch |
| 19 Jul 21 | Jeremy Skillington and Proactive Investors – Poolbeg Pharma | Watch |
| 19 Jul 21 | Luke O’Neill on Poolbeg Pharma | Watch |
